Stericycle Inc. (NASDAQ:SRCL) was downgraded by investment analysts at Northcoast Research from a “buy” rating to a “neutral” rating in a research report issued to clients and investors on Tuesday.

A number of other research firms have also commented on SRCL. Zacks Investment Research lowered Stericycle from a “buy” rating to a “hold” rating in a research note on Monday, July 25th. Imperial Capital lowered Stericycle from an “in-line” rating to an “underperform” rating and lowered their price objective for the stock from $100.00 to $93.50 in a research note on Friday, July 29th. Jefferies Group restated a “buy” rating and set a $125.00 price objective (down previously from $140.00) on shares of Stericycle in a research note on Friday, July 29th. Wellington Shields lowered Stericycle from an “accumulate” rating to a “hold” rating in a research note on Friday, July 29th. Finally, Royal Bank Of Canada restated a “sell” rating on shares of Stericycle in a research note on Thursday, May 26th. Three investment analysts have rated the stock with a sell rating, eleven have assigned a hold rating and three have issued a buy rating to the company’s stock. The company has an average rating of “Hold” and an average target price of $110.32.

Analyst Recommendations for Stericycle (NASDAQ:SRCL)

Stericycle (NASDAQ:SRCL) traded down 0.47% during trading on Tuesday, reaching $77.63. The company’s stock had a trading volume of 531,333 shares. Stericycle has a 1-year low of $77.00 and a 1-year high of $151.57. The stock has a market cap of $6.60 billion, a P/E ratio of 27.32 and a beta of 0.27. The company’s 50 day moving average price is $85.11 and its 200-day moving average price is $102.87.

This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/09/20/stericycle-inc-srcl-downgraded-to-neutral-at-northcoast-research.html

Stericycle (NASDAQ:SRCL) last posted its quarterly earnings data on Thursday, July 28th. The company reported $1.18 EPS for the quarter, hitting the Zacks’ consensus estimate of $1.18. Stericycle had a return on equity of 14.84% and a net margin of 7.22%. The firm had revenue of $891.60 million for the quarter, compared to analyst estimates of $910.29 million. During the same quarter last year, the company earned $1.14 EPS. The company’s revenue was up 24.6% on a year-over-year basis. Equities analysts forecast that Stericycle will post $4.67 earnings per share for the current fiscal year.

In other news, EVP John P. Schetz sold 1,398 shares of the business’s stock in a transaction dated Wednesday, September 14th. The stock was sold at an average price of $81.85, for a total value of $114,426.30. Following the transaction, the executive vice president now directly owns 1,088 shares of the company’s stock, valued at approximately $89,052.80. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Rodney F. Dammeyer sold 10,188 shares of the business’s stock in a transaction dated Wednesday, August 17th. The shares were sold at an average price of $85.50, for a total value of $871,074.00. Following the completion of the transaction, the director now directly owns 10,188 shares in the company, valued at $871,074. The disclosure for this sale can be found here. Company insiders own 3.30% of the company’s stock.

Several hedge funds and other institutional investors have recently made changes to their positions in SRCL. Vanguard Group Inc. increased its position in shares of Stericycle by 1.8% in the second quarter. Vanguard Group Inc. now owns 7,471,494 shares of the company’s stock worth $777,932,000 after buying an additional 135,168 shares in the last quarter. State Street Corp increased its position in shares of Stericycle by 0.5% in the first quarter. State Street Corp now owns 3,593,337 shares of the company’s stock worth $453,442,000 after buying an additional 19,317 shares in the last quarter. Baillie Gifford & Co. increased its position in shares of Stericycle by 77.2% in the second quarter. Baillie Gifford & Co. now owns 2,940,515 shares of the company’s stock worth $306,166,000 after buying an additional 1,281,519 shares in the last quarter. Jana Partners LLC acquired a new position in shares of Stericycle during the first quarter worth about $305,997,000. Finally, BlackRock Institutional Trust Company N.A. increased its position in shares of Stericycle by 0.8% in the first quarter. BlackRock Institutional Trust Company N.A. now owns 2,289,722 shares of the company’s stock worth $288,940,000 after buying an additional 19,063 shares in the last quarter. 92.81% of the stock is currently owned by institutional investors.

About Stericycle

Stericycle, Inc is a business-to-business services provider with a focus on regulated and compliance solutions for healthcare, retail and commercial businesses. The Company’s solutions include the collection and processing of specialized waste for disposal, the collection of personal and confidential information for secure destruction, and a range of training, consulting, recall/return, communication and compliance services.

5 Day Chart for NASDAQ:SRCL

Receive News & Ratings for Stericycle Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle Inc. and related companies with MarketBeat.com's FREE daily email newsletter.